Skip to main content

Despite the headline-negative results of Grail’s multi-cancer early detection trial, an experienced oncologist reveals important lessons beyond the initial outcome. This pioneering randomized trial provides key insights into the future potential and challenges of cancer screening technologies. The oncologist highlights three critical takeaways from the study, emphasizing that the broader implications extend past the trial’s primary results, offering hope for advancements in early cancer detection and improved patient care.

Insights from the First Randomized Trial of Multi-Cancer Early Detection: An Oncologist’s Perspective

Ambient scribes, the pioneering AI application in healthcare, are now being developed to assist patients by efficiently taking notes during doctor visits. This technology aims to enhance medical documentation accuracy and streamline the consultation process from the patient’s perspective.

Introducing AI-Powered Ambient Scribes for Patient Use in Doctor’s Offices

Darshak Sanghavi highlights a growing concern: the financial consequences of healthcare are increasingly impacting patient care itself, creating a complex web where billing practices directly influence clinical outcomes.

Opinion: Navigating the AI Battle in Medical Billing Between Providers and Insurers

In this edition of STAT's AI Prognosis, Brittany Trang explores the pope's recent encyclical on artificial intelligence, highlighting key insights and their significance for Catholic hospitals and the wider health care industry.

Understanding the Pope’s Encyclical on AI: Implications for Catholic Hospitals and the Broader Healthcare Sector

Emergency physician Iyesatta Massaquoi Emeli argues for a fundamental redesign of how patients access healthcare, suggesting that the traditional waiting room model is becoming obsolete. This shift could improve patient experience and streamline care delivery.

Rethinking Patient Access: The Decline of Traditional Doctor’s Office Waiting Rooms

The FDA has failed to meet its own deadline to prohibit the use of electrical shock devices on individuals with intellectual disabilities, prompting strong reactions from disability rights advocates.

FDA Delays Ban on Electrical Shock Devices Despite Advocacy Pressure

Biotech is driving scientific breakthroughs that were once unimaginable. However, Jeremy Levin, a veteran executive in the industry, warns that while the future of biotech looks promising, the institutions supporting these innovations—ranging from regulators and investors to the broader public—face significant challenges that could jeopardize America's leadership in the field.

Jeremy Levin Discusses the Future of Biotech and the Challenges to American Leadership

Democratic lawmakers in Congress are renewing efforts to terminate the Medicare pilot program that employs artificial intelligence to approve or deny medical services.

Congressional Democrats Push to End AI-Based Medicare Prior Authorization Trial

At STAT's Breakthrough Summit West, Jorie Krause's parents shared their story of how artificial intelligence played a crucial role in diagnosing and treating their daughter's ultra-rare condition. They described the moment they saw the impact of AI as almost like flipping a light switch, bringing hope where there was little before.

How AI Transformed Treatment for a Newborn’s Rare Disease

Steve D. Klein emphasizes that while AI has the potential to advance medical decision-making, direct and unregulated exchanges between AI systems and patients, particularly in addiction treatment, carry significant risks.

The Perils of Using AI in Addiction Medicine: A Cautionary Perspective